Revenue fell 8.3% to $3.4B in 2026Q3 with gross margin compressing to 9.1% from 14.2% a year earlier, while SG&A held near $193M and drove a 58.6% operating income decline to $127M, per SFD's income statement.
Smithfield Foods, Inc. (SFD) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Jun'25 | Dec'24 | Dec'23 | Dec'22 | Dec'15 | Dec'14 | Apr'13 | Apr'12 | May'11 | May'10 | May'09 | Apr'08 | Apr'07 | Apr'06 | May'05 | May'04 | Apr'03 | Apr'02 | Apr'01 | Apr'00 | May'99 | May'98 | Apr'97 | Apr'96 | Apr'95 | May'94 | Apr'93 | Apr'92 | Apr'91 | Apr'90 |
|---|
| Sales/Revenue | 15.11B | 0 | 14.14B | 14.64B | 16.2B | 14.44B | 15.03B | 13.22B | 13.09B | 12.2B | 11.2B | 12.49B | 11.35B | 9.36B | 8.83B | 11.25B | 9.18B | 7.14B | 6.6B | 5.9B | 5.15B | 3.77B | 3.87B | 3.87B | 2.38B | 1.53B | 1.45B | 1.14B | 1.05B | 1.07B | 853.4M |
| Revenue Growth % | -0.94% | -100% | -3.4% | -9.62% | 12.19% | -3.94% | 13.69% | 0.97% | 7.31% | 8.93% | -10.29% | 10.01% | 21.28% | 6.02% | -21.52% | 22.56% | 28.63% | 8.03% | 11.95% | 14.55% | 36.44% | -2.39% | -0.08% | 62.36% | 56.17% | 5.47% | 26.68% | 8.75% | -1.98% | 25.59% | - |
| Cost of Goods Sold | 13.26B | 0 | 12.24B | 13.75B | 14.7B | 12.68B | 13.26B | 11.9B | 11.54B | 10.49B | 10.47B | 11.86B | 10.2B | 8.29B | 7.78B | 10.04B | 8.24B | 6.53B | 5.72B | 4.94B | 4.45B | 3.23B | 3.48B | 3.55B | 2.2B | 1.38B | 1.24B | 996.3M | 910.3M | 931.2M | 755.6M |
| COGS % of Revenue | - | - | 86.58% | 93.93% | 90.77% | 87.84% | 88.19% | 90.02% | 88.17% | 85.95% | 93.48% | 94.94% | 89.83% | 88.6% | 88.17% | 89.22% | 89.83% | 91.56% | 86.59% | 83.66% | 86.35% | 85.57% | 89.88% | 91.62% | 92.34% | 90.29% | 85.56% | 87.2% | 86.65% | 86.88% | 88.54% |
| Gross Profit | 1.87B | 0 | 1.9B | 889M | 1.5B | 1.76B | 1.78B | 1.32B | 1.55B | 1.71B | 730.1M | 632.4M | 1.15B | 1.07B | 1.04B | 1.21B | 933.7M | 602.2M | 885.9M | 964.12M | 703.14M | 544.6M | 391.3M | 324.2M | 182.6M | 148.3M | 209M | 146.2M | 140.3M | 140.6M | 97.8M |
| Gross Margin % | 12.37% | - | 13.41% | 6.07% | 9.23% | 12.16% | 11.81% | 9.98% | 11.83% | 14.05% | 6.52% | 5.06% | 10.17% | 11.4% | 11.83% | 10.78% | 10.17% | 8.44% | 13.41% | 16.34% | 13.65% | 14.43% | 10.12% | 8.38% | 7.66% | 9.71% | 14.44% | 12.8% | 13.35% | 13.12% | 11.46% |
| Gross Profit Growth % | - | -100% | 113.39% | -40.54% | -14.83% | -1.14% | 34.55% | -14.83% | -9.61% | 134.78% | 15.45% | -45.23% | 8.26% | 2.14% | -13.87% | 29.84% | 55.05% | -32.02% | -8.11% | 37.12% | 29.11% | 39.18% | 20.7% | 77.55% | 23.13% | -29.04% | 42.95% | 4.21% | -0.21% | 43.76% | - |
| Operating Expenses | 720M | 0 | 780M | 945M | 378M | 961.6M | 844M | 800.4M | 826.8M | 619.1M | 667.3M | 856.3M | 813.6M | 686M | 620.9M | 643.6M | 560.2M | 497.9M | 500.3M | 606.23M | 509.6M | 364.2M | 265.8M | 230.3M | 131.4M | 83.8M | 161.6M | 130.5M | 105.6M | 92.7M | 82M |
| OpEx % of Revenue | - | - | 5.52% | 6.45% | 2.33% | 6.66% | 5.62% | 6.05% | 6.31% | 5.07% | 5.96% | 6.86% | 7.17% | 7.33% | 7.03% | 5.72% | 6.1% | 6.98% | 7.57% | 10.28% | 9.89% | 9.65% | 6.87% | 5.95% | 5.51% | 5.49% | 11.17% | 11.42% | 10.05% | 8.65% | 9.61% |
| Selling, General & Admin | 766M | 0 | 840M | 1.05B | 807M | 973.3M | 902.2M | 815.4M | 816.9M | 789.8M | 705.9M | 798.4M | 813.6M | 686M | 620.9M | 643.6M | 560.2M | 497.9M | 500.3M | 450.96M | 390.63M | 295.6M | 219.9M | 191.2M | 103.1M | 61.7M | 138.6M | 110.4M | 92.8M | 81.1M | 71.8M |
| SG&A % of Revenue | - | - | 5.94% | 7.17% | 4.98% | 6.74% | 6% | 6.17% | 6.24% | 6.47% | 6.3% | 6.39% | 7.17% | 7.33% | 7.03% | 5.72% | 6.1% | 6.98% | 7.57% | 7.64% | 7.58% | 7.83% | 5.69% | 4.94% | 4.32% | 4.04% | 9.58% | 9.66% | 8.83% | 7.57% | 8.41% |
| Research & Development | 0 | 0 | 0 | 0 | 157M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | 0.97% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -2M | 0 | -60M | -105M | -586M | -11.7M | -58.2M | -15M | 9.9M | -170.7M | -38.6M | 57.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155.26M | 118.96M | 68.6M | 45.9M | 39.1M | 28.3M | 22.1M | 23M | 20.1M | 12.8M | 11.6M | 10.2M |
| Operating Income | 1.15B | 841M | 1.12B | -56M | 1.12B | 793.8M | 931.6M | 519.3M | 722.6M | 1.09B | 62.8M | -223.9M | 341M | 380.5M | 423.3M | 568.7M | 373.5M | 104.3M | 385.6M | 357.89M | 193.54M | 180.4M | 125.5M | 93.9M | 51.2M | 64.5M | 47.4M | 15.7M | 34.7M | 47.9M | 15.8M |
| Operating Margin % | 7.62% | - | 7.91% | -0.38% | 6.9% | 5.5% | 6.2% | 3.93% | 5.52% | 8.97% | 0.56% | -1.79% | 3% | 4.07% | 4.79% | 5.06% | 4.07% | 1.46% | 5.84% | 6.07% | 3.76% | 4.78% | 3.25% | 2.43% | 2.15% | 4.23% | 3.28% | 1.37% | 3.3% | 4.47% | 1.85% |
| Operating Income Growth % | - | -24.78% | 2096.43% | -105.01% | 40.72% | -14.79% | 79.4% | -28.13% | -34.01% | 1643.63% | 128.05% | -165.66% | -10.38% | -10.11% | -25.57% | 52.26% | 258.1% | -72.95% | 7.74% | 84.92% | 7.28% | 43.74% | 33.65% | 83.4% | -20.62% | 36.08% | 201.91% | -54.75% | -27.56% | 203.16% | - |
| EBITDA | 1.49B | 1.18B | 1.46B | 371M | 1.56B | 1.03B | 1.16B | 759.2M | 965.4M | 1.33B | 305.1M | 46.6M | 605.2M | 586M | 630.5M | 764.9M | 546.2M | 262.5M | 519.9M | 497.94M | 312.5M | 249M | 171.4M | 133M | 79.5M | 86.6M | 70.4M | 35.8M | 47.5M | 59.5M | 26M |
| EBITDA Margin % | 9.86% | - | 10.3% | 2.53% | 9.61% | 7.12% | 7.73% | 5.74% | 7.37% | 10.87% | 2.72% | 0.37% | 5.33% | 6.26% | 7.14% | 6.8% | 5.95% | 3.68% | 7.87% | 8.44% | 6.07% | 6.6% | 4.43% | 3.44% | 3.33% | 5.67% | 4.86% | 3.13% | 4.52% | 5.55% | 3.05% |
| EBITDA Growth % | -4.3% | -18.94% | 292.72% | -76.17% | 51.47% | -11.57% | 53.11% | -21.36% | -27.24% | 334.91% | 554.72% | -92.3% | 3.28% | -7.06% | -17.57% | 40.04% | 108.08% | -49.51% | 4.41% | 59.34% | 25.5% | 45.27% | 28.87% | 67.3% | -8.2% | 23.01% | 96.65% | -24.63% | -20.17% | 128.85% | - |
| D&A (Non-Cash Add-back) | 338M | 340M | 339M | 427M | 440M | 234.1M | 230.8M | 239.9M | 242.8M | 231.9M | 242.3M | 270.5M | 264.2M | 205.5M | 207.2M | 196.2M | 172.7M | 158.2M | 134.3M | 140.05M | 118.96M | 68.6M | 45.9M | 39.1M | 28.3M | 22.1M | 23M | 20.1M | 12.8M | 11.6M | 10.2M |
| EBIT | 1.1B | 0 | 1.13B | -53M | 1.13B | 781.7M | 932.5M | 398.6M | 710.4M | 1B | 51.8M | -160.4M | 341M | 380.5M | 423.3M | 568.7M | 373.5M | 104.3M | 385.6M | 373.1M | 193.54M | 180.4M | 125.5M | 93.9M | 51.2M | 64.5M | 47.4M | 15.7M | 34.7M | 47.9M | 15.8M |
| Net Interest Income | -30M | 0 | -66M | -76M | -87M | -133.8M | -159.4M | -168.7M | -176.7M | -245.4M | -266.4M | -209.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 30M | 53M | 66M | 76M | 87M | 133.8M | 159.4M | 168.7M | 176.7M | 245.4M | 266.4M | 209.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1M | 0 | -49M | -118M | -75M | -145.9M | -158.5M | -289.4M | -188.9M | -337.9M | -277.4M | -145.6M | -129M | -91.4M | -110.2M | -114.7M | -119.6M | -87.8M | -81.8M | -570K | -73.55M | -36.9M | -44.5M | -26.3M | -20.9M | -14.1M | -14.8M | -11.3M | -1.4M | -4.3M | -5.1M |
| Pretax Income | 1.15B | 308M | 1.07B | -174M | 1.04B | 647.9M | 773.1M | 229.9M | 533.7M | 757.1M | -214.6M | -369.5M | 212M | 289.1M | 313.1M | 454M | 253.9M | 16.5M | 303.8M | 357.32M | 119.99M | 143.5M | 81M | 67.6M | 30.3M | 50.4M | 32.6M | 4.4M | 33.3M | 43.6M | 10.7M |
| Pretax Margin % | 7.63% | - | 7.56% | -1.19% | 6.43% | 4.49% | 5.14% | 1.74% | 4.08% | 6.2% | -1.92% | -2.96% | 1.87% | 3.09% | 3.55% | 4.04% | 2.77% | 0.23% | 4.6% | 6.06% | 2.33% | 3.8% | 2.09% | 1.75% | 1.27% | 3.3% | 2.25% | 0.39% | 3.17% | 4.07% | 1.25% |
| Income Tax | 244M | 308M | 271M | -41M | 231M | 195.6M | 217M | 46.1M | 172.4M | 236.1M | -113.2M | -126.7M | 72.8M | 77.2M | 106.9M | 153.3M | 86.6M | 4.6M | 115.8M | 133.81M | 44.88M | 48.6M | 27.6M | 22.7M | 10.5M | 18.5M | 12.9M | 1.5M | 11.7M | 14.9M | 3.6M |
| Effective Tax Rate % | 21.16% | 100% | 25.35% | 23.56% | 22.17% | 30.19% | 28.07% | 20.05% | 32.3% | 31.18% | 52.75% | 34.29% | 34.34% | 26.7% | 34.14% | 33.77% | 34.11% | 27.88% | 38.12% | 37.45% | 37.4% | 33.87% | 34.07% | 33.58% | 34.65% | 36.71% | 39.57% | 34.09% | 35.14% | 34.17% | 33.64% |
| Net Income | 899M | 0 | 953M | 17M | 870M | 452.3M | 556.1M | 183.8M | 361.3M | 521M | -101.4M | -190.3M | 128.9M | 166.8M | 172.7M | 296.2M | 227.1M | 26.3M | 196.9M | 223.51M | 75.11M | 94.9M | 53.4M | 44.9M | 15.9M | 27.8M | 19.7M | 4M | 21.6M | 28.7M | 7.1M |
| Net Margin % | 5.95% | - | 6.74% | 0.12% | 5.37% | 3.13% | 3.7% | 1.39% | 2.76% | 4.27% | -0.91% | -1.52% | 1.14% | 1.78% | 1.96% | 2.63% | 2.47% | 0.37% | 2.98% | 3.79% | 1.46% | 2.51% | 1.38% | 1.16% | 0.67% | 1.82% | 1.36% | 0.35% | 2.06% | 2.68% | 0.83% |
| Net Income Growth % | 4.05% | -100% | 5505.88% | -98.05% | 92.35% | -18.67% | 202.56% | -49.13% | -30.65% | 613.81% | 46.72% | -247.63% | -22.72% | -3.42% | -41.69% | 30.43% | 763.5% | -86.64% | -11.91% | 197.57% | -20.85% | 77.72% | 18.93% | 182.39% | -42.81% | 41.12% | 392.5% | -81.48% | -24.74% | 304.23% | - |
| Net Income (Continuing) | 909M | 0 | 798M | -133M | 811M | 452.3M | 556.1M | 183.8M | 361.3M | 521M | -101.4M | -242.8M | 139.2M | 211.9M | 206.2M | 300.7M | 167.3M | 11.9M | 188M | 223.51M | 75.11M | 94.9M | 53.4M | 44.9M | 19.8M | 31.9M | 19.7M | 2.9M | 21.6M | 28.7M | 7.1M |
| Discontinued Operations | 0 | 0 | 171M | 155M | 70M | 0 | 0 | 0 | 0 | 0 | 0 | 52.5M | -10.3M | -45.1M | -33.5M | -4.5M | 10.8M | 14.4M | 8.9M | 0 | 0 | 0 | 0 | 0 | -3.9M | -4.1M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 272M | 264M | 225M | 246M | 197M | 54.4M | 50.7M | 13.4M | 2.7M | 3.1M | 4.6M | 18.2M | 16.9M | 13.9M | 18.3M | 27.5M | 13.2M | 4.7M | 18.1M | 48.4M | 32.77M | 57.5M | 5.1M | 0 | 0 | 0 | 3.8M | 2.2M | 1.5M | 1.7M | 1.6M |
| EPS (Diluted) | 2.28 | 0.00 | 2.42 | 0.04 | 2.21 | 1.19 | 1.46 | 1.26 | 2.21 | 3.12 | -0.65 | -1.35 | 0.96 | 1.49 | 1.54 | 2.64 | 2.03 | 0.24 | 1.78 | 4.06 | 1.52 | 2.32 | 0.68 | 0.59 | 0.21 | 0.40 | 1.13 | 0.06 | 0.35 | 0.50 | 0.12 |
| EPS Growth % | 1.79% | -100% | 5501.85% | -98.05% | 85.71% | -18.49% | 15.87% | -42.99% | -29.17% | 580% | 51.85% | -240.63% | -35.57% | -3.25% | -41.67% | 30.05% | 745.83% | -86.52% | -56.16% | 167.11% | -34.48% | 241.18% | 15.25% | 180.95% | -47.5% | -64.6% | 1783.33% | -82.86% | -30% | 316.67% | - |
| EPS (Basic) | - | 0.00 | 2.42 | 0.04 | 2.21 | 1.19 | 1.46 | 1.26 | 2.23 | 3.14 | -0.65 | -1.35 | 0.96 | 1.49 | 1.55 | 2.66 | 2.05 | 0.24 | 1.78 | 4.13 | 1.54 | 2.39 | 0.70 | 0.61 | 0.21 | 0.40 | 1.13 | 0.06 | 0.35 | 0.50 | 0.12 |
| Diluted Shares Outstanding | 394.91M | 0 | 380.07M | 393.11M | 380.07M | 380.07M | 380.07M | 146.4M | 163.5M | 167.2M | 157.1M | 141.1M | 134.2M | 111.9M | 112M | 112.3M | 111.7M | 109.8M | 110.4M | 55.05M | 49.42M | 40.91M | 78.86M | 77.27M | 77.39M | 69.62M | 70.29M | 60M | 62.61M | 57.4M | 59.17M |
| Basic Shares Outstanding | 393.78M | 0 | 380.07M | 393.11M | 380.07M | 380.07M | 380.07M | 145.5M | 162.3M | 166M | 157.1M | 141.1M | 133.9M | 111.7M | 111.1M | 111.2M | 110.1M | 109.6M | 107.18M | 54.12M | 48.77M | 39.71M | 76.16M | 77.27M | 76.96M | 69.62M | 70.29M | 60M | 62.61M | 57.4M | 59.17M |
| Dividend Payout Ratio | - | - | 30.22% | 1900% | 57.01% | 6.63% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.67% | 7.55% | 2.52% | - | 10% | - | - | - |
Quick answers to the most common questions about buying SFD stock.
For fiscal year 2025, Smithfield Foods, Inc. (SFD) reported total revenue of $0.0M. This represents a 100.0% decline compared to $853.4M in 1989.
Smithfield Foods, Inc. (SFD) reported a net loss of $0.0M for the fiscal year ending 2025.
Key Metrics
Top Statement Risk
Feed cost compression on shrinking volumes
Metrics are mathematically derived from official filings.
From Pricing Tailwind to Contraction
Smithfield's top line has swung from +7.0% growth in fiscal 2025Q4 to an 8.3% decline in 2026Q3, per quarterly filings, marking four consecutive quarters of deceleration; this reversal suggests the branded pricing tailwind has expired while volumes appear to be retreating.
The pattern of 2025 (+12.4% in Q3, +7.0% in Q4) followed by sequential negatives in 2026 Q1 through Q3 looks less like seasonality and more like a exhausted pricing cycle, since revenue actually fell from $3.8B to $3.4B at a time when Packaged Meats historically holds. Because SFD's upstream Hog Production segment books revenue at internal transfer economics, the reported decline may understate the true demand weakness in branded volumes; investors should look to segment disclosures to determine whether Fresh Pork throughput, rather than price, is the primary drag.
Feed Costs Eat Into Spread
Gross margin compressed to 9.1% in 2026Q3 from 14.2% a year earlier, based on reported quarterly statements, a 510 basis point erosion that appears driven by feed cost inflation and softer pork pricing rather than mix shift.
For a vertically integrated operator, gross margin reflects the spread between live hog values and grain costs, so a decline of this magnitude implies the hog-to-corn ratio has moved against SFD rather than that the branded portfolio has lost shelf traction. With COGS running $3.1B against $3.4B of sales, even modest feed price relief could restore meaningful margin, but the persistence across three quarters suggests a structural input regime rather than a one-period anomaly. The 9.1% level now sits closer to Tyson's 6.5% than Hormel's 15.6%, hinting that SFD's integrated model is not currently insulating it from commodity swings.
Fixed SG&A Amplifies Margin Loss
SG&A held near $193M in 2026Q3 while gross profit fell roughly 35% year-over-year, according to SFD's income statement, producing a 58.6% operating income decline; the fixed-cost base means every point of gross margin loss is amplified roughly twofold at the operating line.
SG&A has stayed in a narrow $178M–$206M band across eight quarters regardless of revenue direction, which confirms this is largely a fixed overhead structure tied to brand support and plant-level administration rather than a variable selling expense. That rigidity is a double-edged sword: it delivers outsized operating margin (10.4%) in 2025Q4 when gross profit peaked, but converts gross margin erosion into severe operating leverage in the current down-leg. The 2025Q2 outlier of $268M in SG&A, against a quarter of otherwise ordinary results, suggests episodic charges exist within the line and warrants a normalizing view of the underlying run-rate.
Third Quarter Marks Regime Change
The 2026Q3 quarter stands as the clearest inflection, with revenue of $3.4B and gross margin of 9.1% both the weakest in the ten-quarter series, according to reported figures; the roughly $166M gross profit shortfall versus 2025Q3 appears to mark a genuine regime change.
The prior trough of 2024Q1 (10.5% gross, 4.7% operating) proved temporary, with margins recovering to 13–14% for six straight quarters, so the current break below that floor is analytically significant rather than cyclical noise. Management's decision to withhold guidance at the October 2026 report, as noted in recent disclosures, is consistent with a business facing a wider-than-usual outcome range, though it does not by itself confirm the deterioration is permanent. If the combination of negative revenue growth and sub-10% gross margin persists into 2027Q1, the historical mean-reversion assumption embedded in consensus multiples may prove difficult to defend.
Margin Mean-Reversion Under Threat
If feed costs remain elevated and the -8.3% revenue trend persists, Smithfield's 9.1% gross margin could approach the 6.5% level at which diversified peers like Tyson operate, suggesting downside to the mid-single-digit net margins SFD has historically generated.
The bull case rests on the idea that vertical integration structurally caps input volatility, but three consecutive quarters of margin compression indicate that control over genetics and herd ownership does not neutralize grain price exposure when livestock values soften simultaneously. With net margin at 2.6% and EPS down 63.5% year-over-year, any further gross margin loss of even 150 basis points would push operating income toward breakeven given the fixed SG&A base, a scenario that appears plausible if export demand into China weakens under tariff pressure. Additionally, the biological asset revaluation practices common to integrated producers mean reported net income may carry non-cash swings that obscure the true operational trajectory, so investors should weigh the quality, not just the level, of any margin recovery.